View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.
Best Practice Infographic - Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)
Summary Framework for Improving Precision Oncology in NSCLC Findings From The AMCP Market Insights Program
The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
AMCP proceeded to enhance these framework insights by engaging a group of expert managed care and oncology professionals. Their expertise was utilized to identify and validate the following best practices.
For more disease state research, view the Market Insights Program.
Related
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
